[Pharmacological studies of N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid (F1). 3. Interaction with proteins].
D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001168:Arthritis / Q000378:metabolism; D001241:Aspirin / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects; D007191:Indazoles / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D051379:Mice; D010653:Phenylbutazone / Q000494:pharmacology; D010655:Phenylenediamines / Q000494:pharmacology*; D011480:Protease Inhibitors; D011485:Protein Binding / Q000187:drug effects; D011489:Protein Denaturation / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology; D011732:Pyridoxal Phosphate; D051381:Rats; D012710:Serum Albumin, Bovine
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D001593:Benzyl Compounds; D001798:Blood Proteins; D007191:Indazoles; D010655:Phenylenediamines; D011480:Protease Inhibitors; D011720:Pyrazoles; D000632:Aminopyrine; D012710:Serum Albumin, Bovine; D008528:Mefenamic Acid; D011732:Pyridoxal Phosphate; D005439:Flufenamic Acid; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin